Content area
Abstract
PharmaCan Capital is pleased to announce that it has made an investment in the Whistler Medical Marijuana Company (WMMC). "WMMC's Founder and President Christopher Pelz has assembled an outstanding team and we are extremely confident that the company will be granted a license by Health Canada for the commercial production and distribution of medical marihuana under the MMPR in the near future", said PharmaCan's CEO Paul Rosen.
Details
Title
PharmaCan Capital Invests in the Whistler Medical Marijuana Company
Publication year
2013
Publication date
Dec 16, 2013
Source type
Trade Journal
Language of publication
English
ProQuest document ID
1468424808
Copyright
Copyright Marketwire L.P. Dec 16, 2013